Literature DB >> 29407056

Pathogenesis of Cardiovascular Disease in Diabetes.

Andrea V Haas1, Marie E McDonnell2.   

Abstract

The most common cause of death among adults with diabetes is cardiovascular disease (CVD). In this concise review on pathogenesis of CVD in diabetes, the 4 common conditions, atherosclerosis, microangiopathy, diabetic cardiomyopathy, and cardiac autonomic neuropathy, are explored and illustrated to be caused by interrelated pathogenetic factors. Each of these diagnoses can present alone or, commonly, along with others due to overlapping pathophysiology. Although the spectrum of physiologic abnormalities that characterize the diabetes milieu is broad and go beyond hyperglycemia, the authors highlight the most relevant evidence supporting the current knowledge of potent factors that contribute to CVD in diabetes.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac autonomic neuropathy; Coronary flow reserve; Diabetic cardiomyopathy; Diabetic heart disease; Microangiopathy

Mesh:

Year:  2018        PMID: 29407056     DOI: 10.1016/j.ecl.2017.10.010

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  23 in total

Review 1.  Natural Antioxidants Improve the Vulnerability of Cardiomyocytes and Vascular Endothelial Cells under Stress Conditions: A Focus on Mitochondrial Quality Control.

Authors:  Xing Chang; Zhenyu Zhao; Wenjin Zhang; Dong Liu; Chunxia Ma; Tian Zhang; Qingyan Meng; Peizheng Yan; Longqiong Zou; Ming Zhang
Journal:  Oxid Med Cell Longev       Date:  2021-01-22       Impact factor: 6.543

2.  Ultrasonic characteristics and influencing factors of atherosclerosis in diabetic patients.

Authors:  Yanyan Zhao; Shibin Lin; Kailiang Chen; Die Chen; Jineng Lai
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

3.  Cardioprotection stimulated by resveratrol and grape products prevents lethal cardiac arrhythmias in an animal model of ischemia and reperfusion.

Authors:  Francisco Sandro Menezes-Rodrigues; Paolo Ruggero Errante; Erisvaldo Amarante Araújo; Mariana Pontes Pacheco Fernandes; Michele Mendes da Silva; Marcelo Pires-Oliveira; Carla Alessandra Scorza; Fúlvio Alexandre Scorza; Murched Omar Taha; Afonso Caricati-Neto
Journal:  Acta Cir Bras       Date:  2021-05-07       Impact factor: 1.388

Review 4.  Metabolomics of Type 1 and Type 2 Diabetes: Insights into Risk Prediction and Mechanisms.

Authors:  Daniel Gonzalez Izundegui; Matthew Nayor
Journal:  Curr Diab Rep       Date:  2022-02-03       Impact factor: 4.810

5.  Impact of diabetes on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention.

Authors:  Zhen Ye; Qin Chen; Jiaxin Zhong; Long Chen; Lihua Chen; Mingfang Ye; Yuanming Yan; Lianglong Chen; Yukun Luo
Journal:  J Diabetes Investig       Date:  2022-03-29       Impact factor: 3.681

6.  Effects of coenzyme Q10 on cardiovascular and metabolic biomarkers in overweight and obese patients with type 2 diabetes mellitus: a pooled analysis.

Authors:  Haohai Huang; Honggang Chi; Dan Liao; Ying Zou
Journal:  Diabetes Metab Syndr Obes       Date:  2018-11-29       Impact factor: 3.168

Review 7.  The Neuroimmune Role of Intestinal Microbiota in the Pathogenesis of Cardiovascular Disease.

Authors:  Andrey V Suslov; Elizaveta Chairkina; Maria D Shepetovskaya; Irina S Suslova; Victoria A Khotina; Tatiana V Kirichenko; Anton Y Postnov
Journal:  J Clin Med       Date:  2021-05-06       Impact factor: 4.241

8.  Control of Blood Pressure and Cardiovascular Outcomes in Type 2 Diabetes.

Authors:  Hernando Vargas-Uricoechea; Manuel Felipe Cáceres-Acosta
Journal:  Open Med (Wars)       Date:  2018-08-21

9.  ACE-inhibition induces a cardioprotective transcriptional response in the metabolic syndrome heart.

Authors:  Aziza Yakubova; Lieven Thorrez; Dmitry Svetlichnyy; Liesbeth Zwarts; Veerle Vulsteke; Griet Laenen; Wouter Oosterlinck; Yves Moreau; Luc Dehaspe; Jeroen Van Houdt; Álvaro Cortés-Calabuig; Bart De Moor; Patrick Callaerts; Paul Herijgers
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

10.  Overexpression of small ubiquitin‑like modifier 2 ameliorates high glucose‑induced reductions in cardiomyocyte proliferation via the transforming growth factor‑β/Smad pathway.

Authors:  Chen Zhao; Qile Shen
Journal:  Mol Med Rep       Date:  2018-10-01       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.